The renin-angiotensin system in glomerular podocytes: Mediator of glomerulosclerosis and link to hypertensive nephropathy

Current Hypertension Reports

Volumn 8, Issue 2, 2006, Pages 132-138

  Durvasula, Raghu V ^a   Shankland, Stuart J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN; VASCULOTROPIN A;

APOPTOSIS; CELL DAMAGE; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; CYTOSKELETON; DIABETIC NEUROPATHY; DOWNSTREAM PROCESSING; GENE SWITCHING; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; HYPERTENSION, RENAL; KIDNEY GLOMERULUS; PODOCYTES; RENIN-ANGIOTENSIN SYSTEM;

EID: 33744495749     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0009-8     Document Type: Review

References (45)

1. Kincaid-Smith P: Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled "hypertensive nephrosclerosis" J Hypertens 2004, 22:1051-1055.
2. Strippoli GF, Craig M, Deeks JJ, et al.: Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004, 329:828.
3. The GISEN Group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Gruppo Italiano di Studi Epidemiologici in Nefrologia. Lancet 1997, 349:1857-1863.
4. Fogo AB: Renal fibrosis and the renin-angiotensin system. Adv Nephrol Necker Hosp 2001, 31:69-87.
5. Re RN: Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med 2004, 1:42-47.
6. Seikaly MG, Arant BS, Seney FD: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990, 86:1352-1357.
7. Pavenstädt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003, 83:253-307.
8. Wartiovaara J, Ofverstedt LG, Khoshnoodi J, et al.: Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 2004, 114:1475-1483.
9. Kestilä M, Lenkkeri U, Männikkö M, et al.: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575-582.
10. Ruf RG, Lichtenberger A, Karle SM, et al.: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004, 15:722-732.
11. Schwarz K, Simons M, Reiser J, et al.: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001, 108:1621-1629.
12. Shih NY, Li J, Karpitskii V, et al.: Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999, 286:312-315.
13. Roselli S, Heidet L, Sich M, et al.: Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004, 24:550-560.
14. Benzing T: Signaling at the slit diaphragm. J Am Soc Nephro12004, 15:1382-1391.
15. Yu CC, Yen TS, Lowell CA, et al.: Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol 2001, 11:34-38.
16. Foster RR, Saleem MA, Mathieson PW et al.: Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005, 288:F48-F57.
17. Schiffer M, Mundel P, Shaw AS, Böttinger EP: A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J Biol Chem 2004, 279:37004-37012.
18. Steffes MW, Schmidt D, McCrery R, et al.: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001, 59:2104-2113.
19. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al.: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342-348.
20. Kriz W: Podocyte is the major culprit, accounting for the progression of chronic renal disease: Microsc Res Tech 2002, 57:189-195.
21. Wharram BL, Goyal M, Wiggins JF, et al.: Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005, 16:2941-2952.
22. Sharma M, Sharma R, Greene AS, et al.: Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol 1998, 274:F623-F627.
23. Liebau MC, Lang D, Bohm J, et al.: Functional expression of the renin angiotensin system in human podocytes. Am J Physiol Renal Physiol 2005, E pub ahead of print.
24. Xu ZG, Yoo TH, Ryu DR, et al.: Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int 2005, 67:944-952.
25. Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005, 54:1626-1634.
26. Bonnet F, Cooper ME, Kawachi H, et al.: Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001, 44:874-877.
27. Langham RG, Kelly DJ, Cox AJ, et al.: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002, 45:1572-1576.
28. Davis BJ, Cao Z, de Gasparo M, et al.: Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin. J Hypertens 2003, 21:209-216.
29. Mifsud SA, Allen TJ, Bertram JF, et al.: Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade. Diabetologia 2001, 44:878-882.
30. Macconi D, Ghilardi M, Bonassi ME, et al.: Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 2000, 11:477-489.
31. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 2002, 13:3005-3015.
32. Kim NH, Rincon-Choles H, Bhandari B, et al.: Redox dependence of glomerular epithelial cell hypertrophy in response to glucose. Am J Physiol Renal Physiol 2005, Epub ahead of print.
33. Gloy J, Henger A, Fischer KG, et al.: Angiotensin II modulates cellular functions of podocytes. Kidney Int Suppl 1998, 67:S168-S170.
34. Winn MP, Conlon PJ, Lynn KL, et al.: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005, 308:1801-1804.
35. Reiser J, Polu KR, M611er CC, et al.: TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005, 37:739-744.
36. Eremina V, Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 2004, 13:9-15.
37. Kakizawa H, Itoh Y, Imamura S, et al.: Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist. Horm Metab Res 2004, 36:458-464.
38. Chen S, Lee JS, Iglesias-de la Cruz MC, et al.: Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 2005, 20:1320-1328.
39. Abbate M, Zoja C, Morigi M, et al.: Transforming growth factor-beta1 is upregulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol 2002, 161:2179-2193.
40. Ding G, Reddy K, Kapasi AA, et al.: Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002, 283:F173-F180.
41. Durvasula RV, Petermann AT, Hiromura K, et al.: Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004, 65:30-39.
42. Morton MJ, Hutchinson K, Mathieson PW, et al.: Human podocytes possess a stretch-sensitive, Ca2+-activated K+ channel: potential implications for the control of glomerular filtration. J Am Sac Nephrol 2004, 15:2981-2987.
43. Petermann AT, Hiromura K, Blonski M, et al.: Mechanical stress reduces podocyte proliferation in vitro. Kidney Int 2002, 61:40-50.
44. Petermann AT, Pippin J, Durvasula R, et al.: Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 2005, 67:157-166.
45. Hoffmann S, Podlich D, Hahnel B, et al.: Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004, 15:1475-1487.